Both in Pharmaceuticals
Viking Therapeutics vs Amylyx Pharmaceuticals
Over the past year VKTX returned −24.2% and AMLX returned +112.2%; their daily moves had a correlation of 0.29.
VKTX −24.2% AMLX +112.2%Growth of $1, one year, split-adjusted
| Metric | VKTX | AMLX |
|---|---|---|
| Price | $27.28 | $28.86 |
| Market cap | $3.48B | $3.62B |
| Today | +1.56% | +0.63% |
| 1 month | −10.6% | +2.8% |
| 6 months | −9.1% | +80.3% |
| Year to date | −22.5% | +138.9% |
| 1 year | −22.5% | +107.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $709.2M | $250.8M |
| Dividend yield | — | — |
| Volatility (60d) | 86.8% | 112.7% |
| Short % of float | 22.8% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).